Phase II study of docetaxel, cisplatin and modulated oral tegafur (DCT) in advanced gastric cancer (AGC)

被引：0
|
作者：
Pericay, Carles
Losa, Ferran
Nogue, Miquel
Gallardo, Enrique
Fernandez-Morales, Luis
Dalmau, Elsa
Martinez-Peralta, Susana
Santos-Vivas, Cristina
Pous, Enric
Saigi, Eugeni
机构：
[1] Hosp Sabadell, Sabadell, Spain
[2] Hosp Gen lHospitalet, Lhospitalet De Llobregat, Spain
[3] Hosp Gen Vic, Vic, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：324 / 324
页数：1
相关论文
共 50 条
  • [31] Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
    del Muro, XG
    Marcuello, E
    Gumá, J
    Paz-Ares, L
    Climent, MA
    Carles, J
    Parra, MS
    Tisaire, JL
    Maroto, P
    Germá, JR
    BRITISH JOURNAL OF CANCER, 2002, 86 (03) : 326 - 330
  • [32] Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
    X García del Muro
    E Marcuello
    J Gumá
    L Paz-Ares
    M A Climent
    J Carles
    M Sánchez Parra
    J L Tisaire
    P Maroto
    J R Germá
    British Journal of Cancer, 2002, 86 : 326 - 330
  • [33] A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer
    Graziano, F
    Catalano, V
    Baldelli, AM
    Giordani, P
    Testa, E
    Lai, V
    Catalano, G
    Battelli, N
    Cascinu, S
    ANNALS OF ONCOLOGY, 2000, 11 (10) : 1263 - 1266
  • [34] Phase II study with docetaxel (D), cisplatin (C) and continuous capecitabine (X) schedule (DCX) in advanced gastric cancer (AGC): ML21085. Final results.
    Pericay, Caries
    Losa, Ferran
    Alfaro, Jordi
    Cirera, Luis
    Pisa, Aleydis
    Salud, Antonieta
    Falco, Esther
    Casado, Esther
    Nogue, Miguel
    Dotor, Emma
    Serra, Olbia
    Fernandez, Julen
    Saigi, Eugeni
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Phase II trial of weekly docetaxel/fluorouracil/cisplatin in patients with advanced gastric cancer: Preliminary results
    Evangelista, W.
    Racca, P.
    Fanchini, L.
    Ritorto, G.
    Ciorba, A.
    Facilissimo, I
    Napoletano, R.
    Fusco, V
    Alabiso, O.
    ANNALS OF ONCOLOGY, 2008, 19 : 48 - 48
  • [36] A phase II study of simultaneous radiochemotherapy with cisplatin (cDDP) and tegafur in advanced head and neck cancer (AHNC)
    De la Torre, A
    Romero, J
    Regueiro, CA
    Valcarcel, F
    Magallón, R
    Bernal, T
    Martín, M
    Peiró, A
    Montero, A
    Aragón, G
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 927 - 931
  • [37] Phase I Study of Docetaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
    Hironaka, Shuichi
    Yamazaki, Kentaro
    Taku, Keisei
    Yokota, Tomoya
    Shitara, Kohei
    Kojima, Takashi
    Ueda, Shinya
    Machida, Nozomu
    Muro, Kei
    Boku, Narikazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 1014 - 1020
  • [38] Phase II study of combination therapy with docetaxel, cisplatin, and S-1 (DCS) for advanced gastric cancer: (KDOG 0601)
    Nakayama, N.
    Koizumi, W.
    Sasaki, T.
    Tanabe, S.
    Nishimura, K.
    Higuchi, K.
    Takagi, S.
    Katada, C.
    Azuma, M.
    Saigenji, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Phase II study of docetaxel, cisplatin, and 5-fluorouracil (TPF) as first-line chemotherapy in advanced gastric cancer
    Chowdhury, Q.
    Hossain, S.
    Reza, S.
    Hai, M. A.
    Faruqui, M.
    Morshed, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] Phase II study of low-dose docetaxel/fluorouracil/cisplatin in metastatic gastric cancer
    Park, Sook Ryun
    Chun, Jong Ho
    Choi, Jin-Yi
    Kim, Young Woo
    Ryu, Keun Won
    Lee, Jun Ho
    Choi, Il Ju
    Kim, Chan Kyu
    Lee, Jong Seok
    Bae, Jae-Moon
    ANNALS OF ONCOLOGY, 2004, 15 : 239 - 239
12345